Hormonal imbalance can absolutely cause skin darkening, and it does so through several distinct pathways depending on which hormones are involved. The most common forms are melasma (dark patches on the face), acanthosis nigricans (dark, velvety skin in body folds), and generalized hyperpigmentation linked to adrenal or thyroid dysfunction. Each has a different hormonal trigger, appears in different locations, and responds to different approaches.
How Hormones Control Skin Color
Your skin color is determined largely by melanin, a pigment produced by specialized cells called melanocytes. Several hormones can dial melanin production up or down. Estrogen increases melanin synthesis by activating a receptor on the surface of melanocytes called GPER, which triggers a chemical chain reaction inside the cell that ramps up pigment output. Progesterone does the opposite: it works through a different receptor (PAQR7) that suppresses melanin production. Under normal conditions, these two hormones counterbalance each other.
When that balance shifts, as it does during pregnancy, while taking hormonal birth control, or in conditions like polycystic ovary syndrome (PCOS), the scales tip toward excess pigment. But sex hormones aren’t the only players. Insulin, thyroid hormones, and a pituitary hormone called ACTH can each independently drive skin darkening through entirely separate mechanisms.
Melasma: The “Mask of Pregnancy”
Melasma is the most recognized form of hormone-driven skin darkening. It produces brown or grayish patches, most often on the cheeks, forehead, upper lip, and bridge of the nose. Women are affected roughly nine times more often than men, a ratio that underscores the hormonal connection. The condition typically appears during the second trimester of pregnancy, when estrogen and progesterone levels climb sharply, and it can also develop in women using oral contraceptives or hormone replacement therapy.
Hormones alone don’t tell the whole story. Researchers believe sex steroids amplify the effect of ultraviolet radiation on melanin production, meaning sun exposure and hormonal shifts work together to trigger melasma. Genetic background matters too: people with darker skin tones are more susceptible. Among women on oral contraceptives, skin-related side effects occur in roughly 3 to 5 percent of users, and melasma accounts for about two-thirds of those cases.
The encouraging news is that pregnancy-related melasma often fades on its own within about three months after delivery. When it persists, or when it’s triggered by birth control, the darkening can take several months to a year to lighten with treatment, and sun protection is critical to preventing it from returning.
Insulin Resistance and Dark, Velvety Patches
A very different type of hormonal skin darkening shows up in people with insulin resistance, a condition in which the body produces more and more insulin because cells stop responding to it efficiently. The result is acanthosis nigricans: dark, thickened, velvety-textured skin that most commonly appears on the back of the neck, in the armpits, and in the groin folds. It can also affect the elbows, knees, and knuckles.
The mechanism here has nothing to do with melanin. Instead, high circulating insulin binds to growth factor receptors on skin cells, particularly a receptor called IGF-1. This stimulates those cells to multiply rapidly, producing the characteristic thickened, darkened appearance. People with metabolic syndrome also tend to have elevated levels of free IGF-1, which accelerates the process further.
Acanthosis nigricans is strongly linked to type 2 diabetes, obesity, and PCOS. In women with PCOS, it appears alongside other skin changes like acne and excess hair growth. Some research has found associations between acanthosis nigricans and elevated testosterone, increased body weight, and insulin resistance, though the strongest and most consistent driver is the insulin itself. The darkening typically improves when insulin levels come down, whether through weight loss, dietary changes, or medication that improves insulin sensitivity.
Adrenal Insufficiency and Widespread Darkening
One of the most dramatic forms of hormonal hyperpigmentation occurs in Addison’s disease, a condition in which the adrenal glands fail to produce enough cortisol. When cortisol drops, the pituitary gland responds by flooding the bloodstream with ACTH in an attempt to stimulate the adrenals. ACTH binds directly to the same receptor on melanocytes that responds to melanocyte-stimulating hormone, essentially hijacking the pigment pathway and driving melanin production into overdrive.
The darkening in Addison’s disease is distinctive. It tends to be generalized but is most noticeable on sun-exposed skin, the knuckles, elbows, knees, palmar creases, nail beds, and even the inside of the mouth along the gum line and inner cheeks. Scars that formed after the disease began darken noticeably, while older scars stay their original color. This pattern of hyperpigmentation often precedes other symptoms of adrenal insufficiency by months or even years, making it an important early warning sign.
Thyroid Disorders and Skin Color
Thyroid dysfunction is a less commonly recognized cause of skin darkening, but it does occur. Hyperpigmentation is reported more often in hyperthyroidism (overactive thyroid), though case reports document it in hypothyroidism as well. In one published case, a 42-year-old woman developed generalized darkening of the skin that failed to respond to any topical treatment. It resolved only after her subclinical hypothyroidism was treated with thyroid hormone replacement.
The exact mechanism linking low thyroid hormone to hyperpigmentation isn’t fully established. When hypothyroidism occurs as part of an autoimmune process, it can coexist with Addison’s disease, in which case ACTH-driven darkening is the real culprit. But isolated cases of hypothyroidism causing pigment changes have been reported even without adrenal involvement, suggesting that thyroid hormones may influence melanin production through a pathway that isn’t yet well understood.
Where Hormonal Darkening Typically Appears
The location of the darkening often points to its cause:
- Face (cheeks, forehead, upper lip): melasma, driven by estrogen, progesterone, and sun exposure
- Neck, armpits, groin folds: acanthosis nigricans, driven by insulin resistance
- Knuckles, elbows, knees, palmar creases, mouth lining: Addison’s disease, driven by excess ACTH
- Generalized or diffuse darkening: thyroid dysfunction, adrenal insufficiency, or a combination
Darkening that appears only in areas that rub or fold is more likely insulin-related. Darkening that targets sun-exposed areas and skin creases together is more suggestive of adrenal problems. Symmetrical patches confined to the face, especially during pregnancy or while using hormonal birth control, point strongly toward melasma.
How Long It Takes to Fade
The timeline for improvement depends entirely on the underlying cause. Pregnancy-related melasma commonly clears within three months of delivery as hormone levels normalize. Melasma triggered by oral contraceptives may begin to lighten after stopping the medication, but stubborn cases can take six months to a year to respond to treatment. Sun exposure during this period can undo progress quickly.
Acanthosis nigricans improves gradually as insulin resistance decreases. This is a slower process tied to metabolic changes, and visible improvement may take months of sustained effort. In Addison’s disease, hyperpigmentation fades once cortisol is replaced and ACTH levels drop back to normal, though complete resolution can take time. The thyroid-related case described in the medical literature showed significant improvement after the patient began thyroid hormone replacement, though the exact timeline wasn’t specified.
Across all types, the darkening is rarely permanent when the hormonal cause is identified and addressed. But treatments work slowly, and protecting the skin from ultraviolet light is essential during the process. Without sun protection, even corrected hormone levels may not be enough to prevent the pigment from returning.